Medicine & Life Sciences
Carcinosarcoma
83%
Paclitaxel
46%
Drug Therapy
36%
Heterografts
34%
Carboplatin
34%
Ifosfamide
19%
BMS-690514
16%
BMS 754807
15%
Ovarian Neoplasms
14%
veliparib
13%
Mutation
12%
Poly(ADP-ribose) Polymerase Inhibitors
10%
erbB-1 Genes
10%
Comparative Genomic Hybridization
9%
Gene Amplification
9%
Somatomedins
8%
Vascular Endothelial Growth Factor A
6%
Phosphorylation
5%
Clinical Trials
5%
Messenger RNA
4%
Growth
3%
Animals
3%
Therapeutics
3%
Incidence
3%
Genes
3%
Neoplasms
2%
Chemical Compounds
Oncogenic
86%
Paclitaxel
74%
Carboplatin
58%
Ifosfamide
33%
Mutation
26%
BMS-754807
23%
Vasculotropin Inhibitor
21%
Poly(ADPribose)
14%
Resistance
12%
Growth Inhibition
12%
Marker
9%
Agriculture & Biology
carcinosarcoma
100%
drug therapy
61%
paclitaxel
58%
ovarian neoplasms
22%
mutation
15%
polymerase chain reaction
12%
therapeutics
11%
NAD ADP-ribosyltransferase
11%
comparative genomic hybridization
10%
gene overexpression
9%
somatomedins
8%
clinical trials
8%
disease incidence
7%
phosphorylation
6%
growth retardation
6%
neoplasms
5%
animals
3%
testing
3%